A sustainable balance between innovation and risk: How the “right to science” affects China’s medical biotechnology regulatory policy
Medical biotechnology is at the forefront of scientific progress, with humanity facing a critical juncture during the pandemic. However, to maximize these benefits, governments face the complex challenge of reconciling innovation and risk. A sustainable balance is critical, as extreme measures such...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2024-12-01
|
| סדרה: | Computational and Structural Biotechnology Journal |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2001037024001107 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|